Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Sirolimus - Generic Drug Details
« Back to Dashboard
There are sixteen drug master file entries for sirolimus. Seven suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for Generic Name: sirolimus
| Tradenames: | 2 |
| Patents: | 1 |
| Applicants: | 3 |
| NDAs: | 4 |
| Drug Master File Entries: see list | 16 |
| Suppliers / Packaging: see list | 7 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
Pharmacology for Ingredient: sirolimus
| Drug Class | mTOR Inhibitor Immunosuppressant |
| Mechanism of Action | mTOR Inhibitors |
| Physiological Effect | Decreased Immunologic Activity |
Tentative approvals for SIROLIMUS
| Applicant | Application No. | Form | Dosage |
| <disabled> | <disabled> | TABLET; ORAL | 1MG |
Clinical Trials for: sirolimus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pf Prism Cv | RAPAMUNE | sirolimus | TABLET;ORAL | 021110-004 | Jan 25, 2010 | RX | No | May 28, 2022 | |||||||||||||||||||||
Pf Prism Cv | RAPAMUNE | sirolimus | TABLET;ORAL | 021110-003 | Feb 23, 2004 | DISCN | No | 5,989,591*PED | Sep 11, 2018 | Y | |||||||||||||||||||
Dr Reddys Labs Ltd | SIROLIMUS | sirolimus | TABLET;ORAL | 201578-002 | Oct 27, 2014 | RX | No | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents for Generic Ingredient: sirolimus
These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pf Prism Cv | RAPAMUNE | sirolimus | TABLET;ORAL | 021110-003 | Feb 23, 2004 | 5,403,833*PED | <disabled> | ||||||||||||||||||||||
Pf Prism Cv | RAPAMUNE | sirolimus | TABLET;ORAL | 021110-001 | Aug 25, 2000 | 5,403,833*PED | <disabled> | ||||||||||||||||||||||
Pf Prism Cv | RAPAMUNE | sirolimus | SOLUTION;ORAL | 021083-001 | Sep 15, 1999 | 5,100,899*PED | <disabled> | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
To review IP for certain products that are set to expire shortly
— Senior vice president, pharmaceutical wholesaler, Canada
To learn about drugs that will be coming off patent and to offer an ANDA in their master drug file
— Global market development manager, healthcare packaging provider, USA
To study patents on drugs in selected therapeutic areas
— Pharmaceutical process development, India
To get a list of drugs going off patent in USA in the next few years
— Pharmaceutical sales, India
To identify patents near to expiry
— Pharmaceutical company patent reviewer, Pakistan
For Information on historical patent expiration of small molecules by formulation
— Life science strategy consulting, USA
To plan ahead for inventory purposes.
— Pharmacy purchaser, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
